Related Experiment Videos

Antioxidants as adjuvant therapy for cardiovascular disease

Norman E Lepor¹

¹Cedars-Sinai Medical Center, Los Angeles, California, USA.

Reviews in Cardiovascular Medicine

|November 26, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A Placebo-Controlled Trial of the Oral PCSK9 Inhibitor Enlicitide.

The New England journal of medicine·2026

IgG4-Related Disease Presenting With Diffuse Coronary Atherosclerosis Characterized by Marked Lipid-Rich Necrotic Core Burden.

JACC. Case reports·2026

Olpasiran, Oxidized Phospholipids, and Systemic Inflammatory Biomarkers: Results From the OCEAN(a)-DOSE Trial.

JAMA cardiology·2025

The Off-Treatment Effects of Olpasiran on Lipoprotein(a) Lowering: OCEAN(a)-DOSE Extension Period Results.

Journal of the American College of Cardiology·2024

DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases.

Metabolism: clinical and experimental·2024

Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum.

Journal of the American Heart Association·2023

See all related articles